Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dyne Therapeutics, Inc. | 564,313 | reported | 11 Mar 2024 | tx 80+3,115,437−2,756,398 |
| Versartis, Inc. | 201,269 | reported | 19 Oct 2017 | tx 28+450,608−77,266 |
| GLYCOMIMETICS INC | 180,467 | reported | 15 Dec 2025 | tx 4+581,256 |
| PHARMACYCLICS INC | 100,000 | reported | 26 Oct 2012 | tx 2+150,000 |
| Kaleido Biosciences, Inc. | 80,000 | reported | 04 Mar 2019 | tx 1+80,000 |
| Zeltiq Aesthetics Inc | 7,692 | reported | 17 Feb 2012 | tx 2+34,008 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 45,117 | — | |
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 10,000 | — | |
| 15 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 180,467 | 0.00 USD | deriv |
| 08 Dec 2025 | GRANT_AWARD | GLYCOMIMETICS INC | 345,672 | 0.00 USD | deriv |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 153,931 | 5.54 USD | |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 209,412 | 5.54 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 202,238 | 25.30 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 160,670 | 26.72 USD | |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 8,618 | 25.93 USD | |
| 11 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 50,000 | 5.54 USD | |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 40,072 | 25.42 USD | |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 9,928 | 26.10 USD | |
| 11 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 7,769 | 26.12 USD | |
| 08 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 435 | 27.38 USD | |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 153,931 | 0.00 USD | deriv |
| 11 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 08 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 209,412 | 0.00 USD | deriv |
| 07 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 9,086 | 25.85 USD | |
| 01 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 74,090 | 29.23 USD | |
| 01 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 94,480 | 5.54 USD | |
| 01 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 18,976 | 28.25 USD | |
| 29 Feb 2024 | SALE | Dyne Therapeutics, Inc. | 5,520 | 27.50 USD | |
| 01 Mar 2024 | SALE | Dyne Therapeutics, Inc. | 1,414 | 29.70 USD | |
| 29 Feb 2024 | EXERCISE | Dyne Therapeutics, Inc. | 5,520 | 5.54 USD | |
| 01 Mar 2024 | EXERCISE | Dyne Therapeutics, Inc. | 36,637 | 0.00 USD | deriv |